Hooke Bio is excited to announce that we have been selected to receive European Innovation Council (EIC) Accelerator funding (blended finance) announced in June 2023. Only 51 companies were selected in a highly competitive process across Europe out of a total 551 full proposals submitted. The EIC Accelerator supports SMEs to develop and scale up game-changing innovations across Europe.
Mark Lyons, CEO, Hooke Bio said: “Hooke Bio’s Mera platform will be transformative for the drug development process. Our success in the EIC accelerator will allow us to bring this to market faster enabling us to have a positive impact on the lives of patients throughout the world. Enterprise Ireland have played a key role in supporting us on this journey from its very inception.”